G Sachs Raises CSPC PHARMA TP to HKD12.56, Highlights mRNA VaccinesAASTOCKS News·26 minutes ago01093-3.47%
SBP GROUP Gains 3.6% by Midday; BofAS Raises TP to HKD7.1 and Lifts Earnings ForecastsAASTOCKS News·4 hours ago01177+3.80%
Daiwa Raises SBP GROUP TP to HKD7.2 as Interim Adjusted NP Far Beats ForecastsAASTOCKS News·1 day ago, 11:21 PM01177+3.80%
Moderna's cancer-vaccine breakthrough drives broad biopharma stock rallyMarketWatch·1 day ago, 07:28 PMLLY-2.81%AMGN-1.95%
Akeso says China NMPA clears Phase I trial for B7-H3 ADC AK157D1 in solid tumorsPUBT·3 hours ago09926-3.89%
Sino Biopharma rebrands as SBP Group, targets global expansion via direct commercial rollout and partnershipsPUBT·1 day ago, 02:03 AM01177+3.80%
3SBio H1 FY26 net profit rises 26.5% to RMB 1.44 billion; revenue increases 3.9% to RMB 4.53 billionPUBT·1 hour ago01530+8.06%
11:55 ETSino Biopharmaceutical Limited stellt neue globale Marke SBP Group vor, um die internationale Expansion zu beschleunigenprnewswire·1 day ago, 10:56 AM01177+3.80%AZN-0.28%
M Stanley Raises INNOVENT BIO TP to HKD138.5 on Strong 1H Product RevenueAASTOCKS News·2 days ago, 11:26 PM01801+1.19%
BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries | ONC Stock NewsStockTitan·Aug 17 at 09:00 PMBGNE0.00%ONC-2.04%
XtalPi swings to FY26 H1 net loss of RMB 224.94 million; revenue falls 23.87% to RMB 393.63 millionPUBT·1 day ago, 05:11 AM02228-4.16%
Keymed Biosciences swings to FY26 H1 profit of RMB 1.22 billion; revenue rises 24% to RMB 617.07 millionPUBT·1 day ago, 08:24 AM09926-3.89%AZN-0.28%
